Martha Glenn
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 18
- Chronic Lymphocytic Leukemia Research 17
-
- Lymphoma Diagnosis and Treatment 17
- Co-authors
- Stephen A. Strickland (3 shared papers)Joseph Mıkhael (3 shared papers)Karl Hsu (2 shared papers)Éric Charpentier (2 shared papers)Thomas G. Martin (2 shared papers)Andrew D. Zelenetz (4 shared papers)Thomas G. Martin (1 shared paper)André Goy (4 shared papers)
- Journals
- Blood (10 papers)Journal of Clinical Oncology (3 papers)Cancer (2 papers)Blood Cancer Journal (2 papers)Leukemia Research (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Martha Glenn
37 papers receiving 795 citations
Peers
Comparison fields: 5 of 72
- Genetics 250
- Hematology 220
- Pathology and Forensic Medicine 334
- Dermatology 107
- Oncology 275
Countries citing papers authored by Martha Glenn
This map shows the geographic impact of Martha Glenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Glenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Glenn more than expected).
Fields of papers citing papers by Martha Glenn
This network shows the impact of papers produced by Martha Glenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Glenn. The network helps show where Martha Glenn may publish in the future.
Co-authors
The 25 scholars most cited alongside Martha Glenn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 110 | |
| 2 | 2009 | 85 | |
| 3 | 2009 | 74 | |
| 4 | 2019 | 70 | |
| 5 | 2012 | 53 | |
| 6 | 2018 | 46 | |
| 7 | 2014 | 44 | |
| 8 | 2000 | 39 | |
| 9 | 2013 | 32 | |
| 10 | 2004 | 29 | |
| 11 | 2013 | 29 | |
| 12 | 2010 | 29 | |
| 13 | 2019 | 21 | |
| 14 | 2001 | 19 | |
| 15 | 2005 | 16 | |
| 16 | 2002 | 14 | |
| 17 | 2017 | 12 | |
| 18 | 2016 | 10 | |
| 19 | 2004 | 9 | |
| 20 | 2005 | 7 |
About Martha Glenn
Martha Glenn is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Molecular Biology and Oncology, having authored 41 papers that have together received 813 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (17 papers), Acute Lymphoblastic Leukemia research (9 papers), Multiple Myeloma Research and Treatments (5 papers), Glycosylation and Glycoproteins Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Genetics (250 citations), Hematology (220 citations), Pathology and Forensic Medicine (334 citations), Dermatology (107 citations) and Oncology (275 citations). Martha Glenn has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Stephen A. Strickland, Joseph Mıkhael, Karl Hsu, Éric Charpentier, Thomas G. Martin, Andrew D. Zelenetz, Thomas G. Martin, André Goy, Andrzej Kaszuba and Zoé Kececioglu Draelos. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Blood Cancer Journal and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.